Overview

Intercostal Liposomal Bupivacaine for the Management of Blunt Chest Wall Trauma

Status:
Completed
Trial end date:
2021-01-01
Target enrollment:
Participant gender:
Summary
This is a study of liposomal bupivacaine for pain control in patients with blunt chest wall trauma.
Phase:
Phase 2
Details
Lead Sponsor:
University of Cincinnati
Collaborator:
United States Air Force
Treatments:
Bupivacaine